Global Bicalutamide Sales Market Report 2021

1 Bicalutamide Market Overview

• 1.1 Bicalutamide Product Scope
• 1.2 Bicalutamide Segment by Type
  • 1.2.1 Global Bicalutamide Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Tablets
  • 1.2.3 Capsule
• 1.3 Bicalutamide Segment by Application
  • 1.3.1 Global Bicalutamide Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Single Drug For Prostate Cancer
  • 1.3.3 Combined Chemotherapy For Prostate Cancer
  • 1.3.4 Combined Radiation Therapy Or Castration For Prostate Cancer
• 1.4 Bicalutamide Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Bicalutamide Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Bicalutamide Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Bicalutamide Price Trends (2016-2027)

2 Bicalutamide Estimates and Forecasts by Region

• 2.1 Global Bicalutamide Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Bicalutamide Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Bicalutamide Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Bicalutamide Revenue Market Share by Region (2016-2021)
• 2.3 Global Bicalutamide Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Bicalutamide Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Bicalutamide Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Bicalutamide Estimates and Projections (2016-2027)
  • 2.4.2 Europe Bicalutamide Estimates and Projections (2016-2027)
  • 2.4.3 China Bicalutamide Estimates and Projections (2016-2027)
  • 2.4.4 Japan Bicalutamide Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Bicalutamide Estimates and Projections (2016-2027)
  • 2.4.6 India Bicalutamide Estimates and Projections (2016-2027)

3 Global Bicalutamide Competition Landscape by Players

• 3.1 Global Top Bicalutamide Players by Sales (2016-2021)
• 3.2 Global Top Bicalutamide Players by Revenue (2016-2021)
• 3.3 Global Bicalutamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bicalutamide as of 2020)
• 3.4 Global Bicalutamide Average Price by Company (2016-2021)
• 3.5 Manufacturers Bicalutamide Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Bicalutamide Market Size by Type

• 4.1 Global Bicalutamide Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Bicalutamide Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Bicalutamide Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Bicalutamide Price by Type (2016-2021)
• 4.2 Global Bicalutamide Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Bicalutamide Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Bicalutamide Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Bicalutamide Price Forecast by Type (2022-2027)

5 Global Bicalutamide Market Size by Application

• 5.1 Global Bicalutamide Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Bicalutamide Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Bicalutamide Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Bicalutamide Price by Application (2016-2021)
• 5.2 Global Bicalutamide Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Bicalutamide Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Bicalutamide Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Bicalutamide Price Forecast by Application (2022-2027)

6 North America Bicalutamide Market Facts & Figures

• 6.1 North America Bicalutamide Sales by Company
  • 6.1.1 North America Bicalutamide Sales by Company (2016-2021)
  • 6.1.2 North America Bicalutamide Revenue by Company (2016-2021)
• 6.2 North America Bicalutamide Sales Breakdown by Type
  • 6.2.1 North America Bicalutamide Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Bicalutamide Sales Breakdown by Type (2022-2027)
• 6.3 North America Bicalutamide Sales Breakdown by Application
  • 6.3.1 North America Bicalutamide Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Bicalutamide Sales Breakdown by Application (2022-2027)

7 Europe Bicalutamide Market Facts & Figures

• 7.1 Europe Bicalutamide Sales by Company
  • 7.1.1 Europe Bicalutamide Sales by Company (2016-2021)
  • 7.1.2 Europe Bicalutamide Revenue by Company (2016-2021)
• 7.2 Europe Bicalutamide Sales Breakdown by Type
  • 7.2.1 Europe Bicalutamide Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Bicalutamide Sales Breakdown by Type (2022-2027)
• 7.3 Europe Bicalutamide Sales Breakdown by Application
  • 7.3.1 Europe 142 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 142 Sales Breakdown by Application (2022-2027)

8 China Bicalutamide Market Facts & Figures

• 8.1 China Bicalutamide Sales by Company
  • 8.1.1 China Bicalutamide Sales by Company (2016-2021)
  • 8.1.2 China Bicalutamide Revenue by Company (2016-2021)
• 8.2 China Bicalutamide Sales Breakdown by Type
  • 8.2.1 China Bicalutamide Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Bicalutamide Sales Breakdown by Type (2022-2027)
• 8.3 China Bicalutamide Sales Breakdown by Application
  • 8.3.1 China 314 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 314 Sales Breakdown by Application (2022-2027)

9 Japan Bicalutamide Market Facts & Figures

• 9.1 Japan Bicalutamide Sales by Company
  • 9.1.1 Japan Bicalutamide Sales by Company (2016-2021)
  • 9.1.2 Japan Bicalutamide Revenue by Company (2016-2021)
• 9.2 Japan Bicalutamide Sales Breakdown by Type
  • 9.2.1 Japan Bicalutamide Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Bicalutamide Sales Breakdown by Type (2022-2027)
• 9.3 Japan Bicalutamide Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Bicalutamide Market Facts & Figures

• 10.1 Southeast Asia Bicalutamide Sales by Company
  • 10.1.1 Southeast Asia Bicalutamide Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Bicalutamide Revenue by Company (2016-2021)
• 10.2 Southeast Asia Bicalutamide Sales Breakdown by Type
  • 10.2.1 Southeast Asia Bicalutamide Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Bicalutamide Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Bicalutamide Sales Breakdown by Application
  • 10.3.1 Southeast Asia M Pcs Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia M Pcs Sales Breakdown by Application (2022-2027)

11 India Bicalutamide Market Facts & Figures

• 11.1 India Bicalutamide Sales by Company
  • 11.1.1 India Bicalutamide Sales by Company (2016-2021)
  • 11.1.2 India Bicalutamide Revenue by Company (2016-2021)
• 11.2 India Bicalutamide Sales Breakdown by Type
  • 11.2.1 India Bicalutamide Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Bicalutamide Sales Breakdown by Type (2022-2027)
• 11.3 India Bicalutamide Sales Breakdown by Application
  • 11.3.1 India Bicalutamide Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Bicalutamide Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Bicalutamide Business

• 12.1 AstraZeneca
  • 12.1.1 AstraZeneca Corporation Information
  • 12.1.2 AstraZeneca Business Overview
  • 12.1.3 AstraZeneca Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 AstraZeneca Bicalutamide Products Offered
  • 12.1.5 AstraZeneca Recent Development
• 12.2 CORDEN PHARMA GMBH
  • 12.2.1 CORDEN PHARMA GMBH Corporation Information
  • 12.2.2 CORDEN PHARMA GMBH Business Overview
  • 12.2.3 CORDEN PHARMA GMBH Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 CORDEN PHARMA GMBH Bicalutamide Products Offered
  • 12.2.5 CORDEN PHARMA GMBH Recent Development
• 12.3 Zeneca GmbH
  • 12.3.1 Zeneca GmbH Corporation Information
  • 12.3.2 Zeneca GmbH Business Overview
  • 12.3.3 Zeneca GmbH Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Zeneca GmbH Bicalutamide Products Offered
  • 12.3.5 Zeneca GmbH Recent Development
• 12.4 Actavis Pharma
  • 12.4.1 Actavis Pharma Corporation Information
  • 12.4.2 Actavis Pharma Business Overview
  • 12.4.3 Actavis Pharma Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Actavis Pharma Bicalutamide Products Offered
  • 12.4.5 Actavis Pharma Recent Development
• 12.5 Sivem Pharmaceuticals
  • 12.5.1 Sivem Pharmaceuticals Corporation Information
  • 12.5.2 Sivem Pharmaceuticals Business Overview
  • 12.5.3 Sivem Pharmaceuticals Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Sivem Pharmaceuticals Bicalutamide Products Offered
  • 12.5.5 Sivem Pharmaceuticals Recent Development
• 12.6 Sorres Pharma
  • 12.6.1 Sorres Pharma Corporation Information
  • 12.6.2 Sorres Pharma Business Overview
  • 12.6.3 Sorres Pharma Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Sorres Pharma Bicalutamide Products Offered
  • 12.6.5 Sorres Pharma Recent Development
• 12.7 Fresenius Kabi
  • 12.7.1 Fresenius Kabi Corporation Information
  • 12.7.2 Fresenius Kabi Business Overview
  • 12.7.3 Fresenius Kabi Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Fresenius Kabi Bicalutamide Products Offered
  • 12.7.5 Fresenius Kabi Recent Development
• 12.8 ANI Pharmaceuticals
  • 12.8.1 ANI Pharmaceuticals Corporation Information
  • 12.8.2 ANI Pharmaceuticals Business Overview
  • 12.8.3 ANI Pharmaceuticals Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 ANI Pharmaceuticals Bicalutamide Products Offered
  • 12.8.5 ANI Pharmaceuticals Recent Development
• 12.9 Accel Pharma
  • 12.9.1 Accel Pharma Corporation Information
  • 12.9.2 Accel Pharma Business Overview
  • 12.9.3 Accel Pharma Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Accel Pharma Bicalutamide Products Offered
  • 12.9.5 Accel Pharma Recent Development
• 12.10 Apotex Corporation
  • 12.10.1 Apotex Corporation Corporation Information
  • 12.10.2 Apotex Corporation Business Overview
  • 12.10.3 Apotex Corporation Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Apotex Corporation Bicalutamide Products Offered
  • 12.10.5 Apotex Corporation Recent Development
• 12.11 Shanghai Fudan Fuhua Pharmaceutical
  • 12.11.1 Shanghai Fudan Fuhua Pharmaceutical Corporation Information
  • 12.11.2 Shanghai Fudan Fuhua Pharmaceutical Business Overview
  • 12.11.3 Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Products Offered
  • 12.11.5 Shanghai Fudan Fuhua Pharmaceutical Recent Development
• 12.12 Shanghai Zhaohui Pharmaceutical
  • 12.12.1 Shanghai Zhaohui Pharmaceutical Corporation Information
  • 12.12.2 Shanghai Zhaohui Pharmaceutical Business Overview
  • 12.12.3 Shanghai Zhaohui Pharmaceutical Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
  • 12.12.4 Shanghai Zhaohui Pharmaceutical Bicalutamide Products Offered
  • 12.12.5 Shanghai Zhaohui Pharmaceutical Recent Development
• 12.13 Zhejiang Haizheng Pharmaceutical
  • 12.13.1 Zhejiang Haizheng Pharmaceutical Corporation Information
  • 12.13.2 Zhejiang Haizheng Pharmaceutical Business Overview
  • 12.13.3 Zhejiang Haizheng Pharmaceutical Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
  • 12.13.4 Zhejiang Haizheng Pharmaceutical Bicalutamide Products Offered
  • 12.13.5 Zhejiang Haizheng Pharmaceutical Recent Development
• 12.14 Shanxi Zhendong Pharmaceutical
  • 12.14.1 Shanxi Zhendong Pharmaceutical Corporation Information
  • 12.14.2 Shanxi Zhendong Pharmaceutical Business Overview
  • 12.14.3 Shanxi Zhendong Pharmaceutical Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
  • 12.14.4 Shanxi Zhendong Pharmaceutical Bicalutamide Products Offered
  • 12.14.5 Shanxi Zhendong Pharmaceutical Recent Development

13 Bicalutamide Manufacturing Cost Analysis

• 13.1 Bicalutamide Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Bicalutamide
• 13.4 Bicalutamide Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Bicalutamide Distributors List
• 14.3 Bicalutamide Customers

15 Market Dynamics

• 15.1 Bicalutamide Market Trends
• 15.2 Bicalutamide Drivers
• 15.3 Bicalutamide Market Challenges
• 15.4 Bicalutamide Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List